Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum (Q62116485)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

1 reference

1 reference

1 reference

3''-O-(4-Hydroxycinnamoyl)cosmosiin

1 reference

isorhamnetin 3-O-glucoside

1 reference

(+)-Lariciresinol 4,4'-bis(beta-D-glucopyranoside)

1 reference

(2R,3S,4R,5R,6S)-2-[4-[(2R,3S,4S)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

5,6,7-trihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one

1 reference

1 reference

1 reference

4',5,7-Trihydroxy-3'-methoxy-3-(6-O-acetyl-beta-D-glucopyranosyloxy)flavone

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one

1 reference

(2R,3S,4R,5R,6S)-2-[4-[[(3S,4S,5R)-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methyl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

1 reference

QFUYJSDAALMTEV-UQUOMIKKSA-N

1 reference

5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one

1 reference

1 reference

[(2R,3S,4S,5R,6S)-6-{[5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate

1 reference

1 reference

2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-2-hydroxybutanedioic acid

1 reference

1 reference

1 reference

1 reference

1 reference

6-hydroxy-4',5,7-trimethoxyflavone

1 reference

(2R)-1,1-dimethylpyrrolidin-1-ium-2-carboxylate

1 reference

1 reference

[(2R,3R,4R,5R,6R)-4-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3S,4R,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

1 reference

4',5,6,7-tetramethoxyflavone

1 reference

1 reference

1 reference

5,6,7,8,4'-Pentahydroxyflavone

1 reference

[(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-[[(2S,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

1 reference

[(2R,3R,4S,5R,6S)-3,5-dihydroxy-6-[5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-7-yl]oxy-4-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]methyl (E)-3-phenylprop-2-enoate

6'-Glucosyl-martynoside

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

[(2R,3R,4S,5R,6S)-3,5-dihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-4-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]methyl (E)-3-phenylprop-2-enoate

1 reference

1 reference

2beta-(3-Methoxy-4-hydroxyphenyl)-4alpha-[4-(beta-D-glucopyranosyloxy)-3-methoxybenzyl]tetrahydrofuran-3alpha-methanol

1 reference

(2S,3R,4R,5S,6R)-2-(hydroxymethyl)-6-[4-[[(3S,4S,5R)-4-(hydroxymethyl)-5-[3-methoxy-4-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]oxolan-3-yl]methyl]-2-methoxyphenoxy]oxane-3,4,5-triol

1 reference

1 reference

2beta-[3-Methoxy-4-(beta-D-glucopyranosyloxy)phenyl]-4alpha-(4-hydroxy-3-methoxybenzyl)tetrahydrofuran-3alpha-methanol

1 reference

1 reference

1 reference

1 reference

1 reference

D-Rha(a1-3)[coumaroyl(3-OH)(-4)]b-Glc

1 reference

1 reference

1 reference

1 reference

[5,6-Dihydroxy-2-(hydroxymethyl)-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl] 3-(3,4-dihydroxyphenyl)prop-2-enoate

1 reference

[5-Hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl] 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

1 reference

[2-[[3,4-Dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-5-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethoxy]-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl] 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

1 reference

[4-[4,5-Dihydroxy-6-methyl-3-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxy-5-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl] 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

1 reference

5,6,7-Trihydroxy-2-(4-hydroxyphenyl)-3-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-4-one

1 reference

[3,5-Dihydroxy-6-[5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-7-yl]oxy-4-[3-(4-hydroxyphenyl)prop-2-enoyloxy]oxan-2-yl]methyl 3-phenylprop-2-enoate

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Helen Skaltsa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Anastasia Protopappa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Nikolaos Megoulas

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287127%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry

25 December 2019

language of work or name

English

0 references

publication date

April 2007

1 reference

16 September 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

2708-2714

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287127%20AND%20SRC:MED&resulttype=core&format=json

Tyrosinase inhibitors from Rhododendron collettianum and their structure-activity relationship (SAR) studies.

25 December 2019

cites work

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.52.1458

Studies on a novel p-coumaroyl glucoside of apigenin and on other flavonoids isolated from patchouli (Labiatae).

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.29.254

Studies of cuticle drugs from natural sources. III. Inhibitory effect of Myrica rubra on melanin biosynthesis

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/BPB.18.1148

Identifiers

DOI

10.1016/J.BMC.2007.01.035

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287127%20AND%20SRC:MED&resulttype=core&format=json